STOCK TITAN

Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Oculis has disclosed multiple notifications regarding transactions executed by a Person Discharging Managerial Responsibilities (PDMR) under a pre-planned 10b5-1 trading plan. The sales transactions were conducted by R. Sherif over five consecutive days from March 14-20, 2025, in compliance with Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934.

Oculis ha divulgato diverse notifiche riguardanti transazioni eseguite da una Persona che Svolge Funzioni Direttive (PDMR) nell'ambito di un piano di trading predefinito 10b5-1. Le transazioni di vendita sono state effettuate da R. Sherif in cinque giorni consecutivi dal 14 al 20 marzo 2025, in conformità con la Regola 10b5-1(c)(1) del Securities Exchange Act del 1934.

Oculis ha divulgado múltiples notificaciones sobre transacciones realizadas por una Persona que Desempeña Funciones de Gestión (PDMR) bajo un plan de negociación preestablecido 10b5-1. Las transacciones de venta fueron realizadas por R. Sherif durante cinco días consecutivos del 14 al 20 de marzo de 2025, de acuerdo con la Regla 10b5-1(c)(1) de la Ley de Intercambio de Valores de 1934.

Oculis는 사전 계획된 10b5-1 거래 계획에 따라 관리 책임을 수행하는 개인(PDMR)이 실행한 거래에 대한 여러 통지를 공개했습니다. 판매 거래는 2025년 3월 14일부터 20일까지 R. Sherif에 의해 연속 5일 동안 수행되었으며, 이는 1934년 증권 거래법 제10b5-1(c)(1) 규정에 따른 것입니다.

Oculis a divulgué plusieurs notifications concernant des transactions exécutées par une Personne exerçant des Fonctions Managériales (PDMR) dans le cadre d'un plan de trading préétabli 10b5-1. Les transactions de vente ont été réalisées par R. Sherif sur cinq jours consécutifs du 14 au 20 mars 2025, conformément à la Règle 10b5-1(c)(1) de la Loi sur les Échanges de Valeurs de 1934.

Oculis hat mehrere Mitteilungen über Transaktionen veröffentlicht, die von einer Person mit Führungsverantwortung (PDMR) im Rahmen eines vorab geplanten 10b5-1-Handelsplans durchgeführt wurden. Die Verkaufstransaktionen wurden von R. Sherif über fünf aufeinanderfolgende Tage vom 14. bis 20. März 2025 in Übereinstimmung mit Regel 10b5-1(c)(1) des Securities Exchange Act von 1934 durchgeführt.

Positive
  • Transactions executed through proper regulatory channels via 10b5-1 trading plan
Negative
  • Multiple insider stock sales by PDMR could signal reduced confidence in company prospects

ZUG, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to trades entered into by a PDMR of the Company pursuant to a 10b5-1 trading plan, in accordance with Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended.

Attachments


FAQ

What type of transactions did Oculis (OCS) report in March 2025?

Oculis reported multiple stock sales transactions by PDMR R. Sherif, executed under a 10b5-1 trading plan between March 14-20, 2025.

Who conducted the reported stock sales at Oculis (OCS)?

R. Sherif, a Person Discharging Managerial Responsibilities (PDMR) at Oculis, conducted the reported stock sales.

What is the regulatory framework governing these Oculis (OCS) transactions?

The transactions were executed under Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, which allows for pre-planned trading by company insiders.

When did the reported Oculis (OCS) PDMR transactions take place?

The transactions occurred over five consecutive days from March 14 through March 20, 2025.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Stock Data

803.46M
43.64M
7.04%
31.04%
0.05%
Biotechnology
Healthcare
Link
Switzerland
Zug